Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.

MLA

Wasehuus, Victor, et al. “Effect of Spironolactone Wash-out on Albuminuria after Long-Term Treatment in Individuals with Type 2 Diabetes and High Risk of Kidney Disease-An Observational Follow-up of the PRIORITY Study.” Diabetes, Obesity & Metabolism, vol. 27, no. 1, Jan. 2025, pp. 387–93. EBSCOhost, https://doi.org/10.1111/dom.16037.

APA

Wasehuus, V., Rotbain Curovic, V., Tofte, N., Lindhardt, M., Currie, G., Delles, C., Frimodt-Møller, M., Mischak, H., von der Leyen, H., Hansen, T. W., Kümler, T., Persson, F., & Rossing, P. (2025). Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study. Diabetes, Obesity & Metabolism, 27(1), 387–393. https://doi.org/10.1111/dom.16037

Chicago

Wasehuus, Victor, Viktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, Gemma Currie, Christian Delles, Marie Frimodt-Møller, et al. 2025. “Effect of Spironolactone Wash-out on Albuminuria after Long-Term Treatment in Individuals with Type 2 Diabetes and High Risk of Kidney Disease-An Observational Follow-up of the PRIORITY Study.” Diabetes, Obesity & Metabolism 27 (1): 387–93. doi:10.1111/dom.16037.